Solace Health, a patient advocacy platform, extends coverage to most major health plans, including UnitedHealthcare and Anthem Blue Cross Blue Shield.
Solace previously connected Medicare and Medicare Advantage patients to its services, but it is now also available to many commercially insured patients. Other commercial projects with which the company is currently a partner were not specified in the press release. Solace pairs each patient with a dedicated medical advocate to help navigate care.
Health care systems are complex, and patients are often required to coordinate their own care, interpret advice, manage records, and resolve billing issues. A 2025 study found that more than 60% of U.S. adults have inadequate health literacy. Solace aims to fill this gap.
Solace CEO Jeremy Gurewitz and Chief Product Officer Sarah Sargent founded the company in 2022 after Gurewitz’s mother was diagnosed with pancreatic cancer in 2016. His mother was a doctor, but the family still had difficulty caring for her.
“No one should have to manage the health care system alone,” Gurewitz said in a press release. “Patients are expected to take on a disproportionate amount of administrative and emotional labor at the very moment they are least equipped to do so. This expansion will give millions more Americans access to qualified legal counsel when they need it most.”
For every hour Solace advocates spend with a patient, they spend additional time coordinating care, responding to insurance inquiries, arranging appointments, and tracking progress. Solace’s data shows this is resonating. After working with a Solace advocate, the company claims that 98% of patients feel more in control and 92% experience measurable improvements in their health. This data is based on a 2023 report by the Coalition of Healthcare Advocacy Organizations.
Earlier this year, Solace raised $130 million in Series C from investors including IVP, Menlo Ventures, and Torch Capital. Solas hopes to use the proceeds to expand its national network of advocates, valuing the company at $1 billion. As of February, Solace has 2,000 supporters and serves more than 20,000 patients each month.
